Clinical trial
Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children by Providing Prebiotic Galacto-oligosaccharides As Adjunct Treatment: a Randomized Controlled Trial
NCT04931641 is registered in ClinicalTrials.gov with Swiss Federal Institute of Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children by Providing Prebiotic Galacto-oligosaccharides As Adjunct Treatment: a Randomized Controlled Trial
- Lead sponsor
- Swiss Federal Institute of Technology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2021
- Completion date
- October 4, 2022
- Enrollment
- 86 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv, iron deficiency